v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Feb. 27, 2026
Feb. 28, 2025
Cash flows from operating activities    
Net income (loss) $ 44,596 $ 14,835
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by operating activities:    
Depreciation expense and amortization of intangible assets 25,570 28,998
Amortization of debt issuance costs 1,316 1,903
Stock-based compensation expense 15,199 23,111
Impairment of goodwill 0 6,079
Loss on impairment of non-marketable equity investment 10,000 0
Gain on disposition of equity investment (27,036) 0
Deferred income taxes, net 30 163
Other 903 (1,428)
Changes in operating assets and liabilities:    
Accounts receivable (62,705) (78,640)
Inventories (67,178) (46,165)
Other assets (2,809) 15,720
Accounts payable and accrued expenses and other liabilities 148,124 122,120
Net cash provided by operating activities 86,010 86,696
Cash flows from investing activities    
Capital expenditures and deposits on equipment (4,456) (4,171)
Proceeds from sales and maturities of investment securities 0 14,835
Purchases of held-to-maturity investment securities 0 (33,394)
Proceeds from disposition of equity investments 32,186 0
Other (840) (541)
Net cash provided by (used for) investing activities 26,890 (23,271)
Cash flows from financing activities    
Proceeds from issuance of preferred shares, net of $8,818 paid issuance costs 0 191,182
Repayments of debt (20,000) 0
Payments to acquire common stock (57,134) (17,595)
Payment of preferred stock cash dividends (6,200) (2,233)
Proceeds from issuance of common stock 5,852 3,742
Net cash (used for) provided by financing activities (77,482) 175,096
Net increase (decrease) in cash, cash equivalents and restricted cash 35,418 238,521
Cash, cash equivalents and restricted cash at beginning of period 454,070 383,477
Cash, cash equivalents and restricted cash at end of period $ 489,488 $ 621,998